A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Clinical trial NCT02424617 · COMPLETED
Trial details
- NCT number
- NCT02424617
- Sponsor
- BerGenBio ASA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-19
- Primary completion
- 2021-08-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.